McDermott Will & Emery has expanded its IP practice with Michael Siekman and Jenny Chen who will be partners in the firm’s Boston office supporting the firm’s life sciences and healthcare work.
“We are laser focused on smart expansion, and virtually every McDermott practice group and geography is focused on legal representation for the life sciences sector,” said McDermott head of strategy Michael Poulos.
Siekman and Chen come from Polsinelli, which did not immediately respond to request for comment on the duo’s departure.
Siekman counsels clients in the biotechnology and pharmaceutical industries on a broad range of intellectual property concerns and has more than 25 years experience in the field. Prior to joining Polsinelli in April 2019, he was in the biotechnology practice at law firm Wolf Greenfield for 15 years.
Chen, who has a PhD in pharmacology in addition to a law degree, also had been at Wolf Greenfield prior to joining Polsinelli, advising biotech and life sciences clients on patent-related issues.
McDermott has been busy of late growing in several practice areas via lateral hires, in spite of the disruption the coronavirus epidemic has brought to Big Law.
The firm of about 1,200 attorneys grew its international trade practice in Washington at the end of July by adding seven lawyers from Hughes Hubbard & Reed, including two of that firm’s former practice chairs.
Also last month, the firm added to its restructuring practice by scooping up a five-lawyer group from Katten Muchin Rosenman for its restructuring and insolvency practice in Dallas. Lateral movement in bankruptcy and restructuring has been frequent because of the increasing demand for legal services from companies under financial stress.
Earlier this month, McDermott also bolstered its capabilities on the West Coast, adding one of the leaders of Quinn Emanuel Urquhart & Sullivan’s national media and entertainment practice. That was the third lawyer from Quinn Emanuel to depart for McDermott over a several-week period.